ALX Oncology (ALXO) News Today → Trump’s “Tax Free” Retirement Strategy (From Gold Safe Exchange) (Ad) Free ALXO Stock Alerts $16.21 -0.74 (-4.37%) (As of 05/10/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineAnalysts Offer Insights on Healthcare Companies: Zevra Therapeutics (ZVRA), ALX Oncology Holdings (ALXO) and Quoin Pharmaceuticals (QNRX)markets.businessinsider.com - May 10 at 5:25 PMALX Oncology Holdings Inc (ALXO) Q1 2024 Earnings Analysis: A Detailed Look at Financials and ...finance.yahoo.com - May 10 at 5:25 PMJaume Pons Sells 20,000 Shares of ALX Oncology Holdings Inc. (NASDAQ:ALXO) Stockamericanbankingnews.com - May 10 at 5:50 AMALXO Stock Earnings: ALX Oncology Holdings Beats EPS for Q1 2024investorplace.com - May 10 at 12:09 AMALX Oncology Reports First Quarter 2024 Financial Results and Provides Corporate Updateglobenewswire.com - May 9 at 4:00 PMALX Oncology Holdings Inc. (NASDAQ:ALXO) Insider Sells $318,400.00 in Stockinsidertrades.com - May 9 at 9:12 AMALX Oncology (NASDAQ:ALXO) Trading Up 6.8%marketbeat.com - May 7 at 7:24 PMALX Oncology Appoints Allison Dillon as Chief Business Officerglobenewswire.com - May 7 at 9:00 AMRelay Therapeutics GAAP EPS of -$0.62 beats by $0.10, revenue of $10.01M beats by $9.09Mmsn.com - May 3 at 2:52 AMALX Oncology Announces Initiation of Phase 2 Investigator-Sponsored Trial of Neoadjuvant Radiation and Evorpacept in Combination with Pembrolizumab in Patients with Untreated HPV-Mediated Oropharyngeal Cancerfinance.yahoo.com - April 30 at 9:53 AM66,211 Shares in ALX Oncology Holdings Inc. (NASDAQ:ALXO) Bought by abrdn plcmarketbeat.com - April 30 at 5:00 AMALX Oncology (NASDAQ:ALXO) Hits New 52-Week High at $17.45marketbeat.com - April 29 at 3:53 PMFederated Hermes Inc. Sells 54,824 Shares of ALX Oncology Holdings Inc. (NASDAQ:ALXO)marketbeat.com - April 28 at 5:12 AMALX Oncology Announces Two Evorpacept Abstracts Accepted for Poster Presentation at 2024 ASCO Annual Meetingglobenewswire.com - April 24 at 10:00 AMALX Oncology (NASDAQ:ALXO) Trading Up 9.1%marketbeat.com - April 23 at 4:47 PMALX Oncology (NASDAQ:ALXO) Shares Down 4.8% marketbeat.com - April 22 at 4:46 PMAlx Oncology's president & CSO sells $710k in stockinvesting.com - April 20 at 8:41 AMALX Oncology Holdings Inc. (NASDAQ:ALXO) Insider Sells $710,000.00 in Stockinsidertrades.com - April 19 at 6:40 AMALX Oncology Holdings Inc. (NASDAQ:ALXO) Insider Jaume Pons Sells 50,000 Sharesmarketbeat.com - April 18 at 6:44 PMALX Oncology: Trying To Justify The Hypeseekingalpha.com - April 18 at 1:26 PMENPH, OCUL and ITCI are among after hour moversseekingalpha.com - April 18 at 2:06 AMALX Oncology (NASDAQ:ALXO) Trading Up 6.5%marketbeat.com - April 17 at 11:57 AMALX Oncology (NASDAQ:ALXO) Sees Large Volume Increasemarketbeat.com - April 16 at 3:44 PMALX Oncology hold rating reiterated with steady stock target by Stifeluk.investing.com - April 13 at 12:02 AMALX Oncology's (ALXO) Overweight Rating Reiterated at Cantor Fitzgeraldmarketbeat.com - April 12 at 10:22 AMALX Oncology (NASDAQ:ALXO) Trading 4.2% Higher marketbeat.com - April 11 at 2:49 PMBuy Rating on ALX Oncology Holdings Amid Strong Clinical Data and Favorable rNPV Analysismarkets.businessinsider.com - April 11 at 12:07 AMALX Oncology's (ALXO) "Buy" Rating Reiterated at HC Wainwrightmarketbeat.com - April 10 at 11:26 AMALX Oncology Reports Encouraging Clinical Data of Evorpacept in Combination with Standard-of-Care in an Ongoing Phase 1/2 Clinical Trial in Patients with Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (“R/R B-NHL”)globenewswire.com - April 9 at 5:30 PMBuy Rating Justified by Promising Evorpacept Trial Results and Market Potentialmarkets.businessinsider.com - April 8 at 3:00 PMALX Oncology Holdings Inc. (NASDAQ:ALXO) Insider Jaume Pons Sells 20,000 Sharesinsidertrades.com - April 6 at 7:44 AMALX Oncology Holdings Inc (ALXO) Insider Sells Sharesfinance.yahoo.com - April 6 at 6:48 AMALX Oncology (NASDAQ:ALXO) Trading Up 3.6%marketbeat.com - April 4 at 6:21 PMALX Oncology (NASDAQ:ALXO) Shares Gap Up to $11.19marketbeat.com - March 27 at 11:47 AMALX Oncology (NASDAQ:ALXO) Shares Down 3.6% marketbeat.com - March 26 at 4:46 PMAlx Oncology CEO buys $49.7k in company sharesinvesting.com - March 20 at 8:57 AMALX Oncology (NASDAQ:ALXO) Shares Gap Up Following Insider Buying Activitymarketbeat.com - March 19 at 10:33 AMALX Oncology Holdings Inc. (NASDAQ:ALXO) CEO Jason Lettmann Acquires 4,400 Sharesinsidertrades.com - March 19 at 5:42 AMALX Oncology Holdings Inc. (NASDAQ:ALXO) CEO Jason Lettmann Buys 4,400 Sharesmarketbeat.com - March 18 at 5:32 PMALXO Apr 2024 7.000 putfinance.yahoo.com - March 17 at 10:01 AMALXO Apr 2024 19.000 callfinance.yahoo.com - March 16 at 9:12 AMALXO Apr 2024 14.000 putfinance.yahoo.com - March 16 at 9:12 AMQ1 2024 Earnings Forecast for ALX Oncology Holdings Inc. Issued By HC Wainwright (NASDAQ:ALXO)marketbeat.com - March 14 at 6:40 AMALX Oncology (NASDAQ:ALXO) Trading Down 4%marketbeat.com - March 11 at 11:53 AMALX Oncology’s Evorpacept Shows Promising Potential in Cancer Treatment Studiesmarkets.businessinsider.com - March 8 at 3:10 PMALX Oncology Has 'Elevated Valuation' - Analyst Downgrades Stock, Highlights Need For Development De-Risking Beyond Gastric Cancermarkets.businessinsider.com - March 8 at 3:10 PMALX Oncology just downgraded at Stifel, here's whyrealmoney.thestreet.com - March 8 at 10:10 AMStifel Nicolaus Lowers ALX Oncology (NASDAQ:ALXO) to Holdmarketbeat.com - March 8 at 7:40 AMALX Oncology Holdings Inc (ALXO) Reports Growth Amidst Increased R&D Spendingfinance.yahoo.com - March 8 at 12:16 AMALXO Stock Earnings: ALX Oncology Holdings Beats EPS for Q4 2023investorplace.com - March 8 at 12:16 AM Get ALX Oncology News Delivered to You Automatically Sign up to receive the latest news and ratings for ALXO and its competitors with MarketBeat's FREE daily newsletter. Email Address Biggest hedge fund manager has huge warning for U.S. dollar (Ad)Prescient CEO Makes Shocking New Prediction Known for his eerily accurate market calls over the years, this CEO has just revealed his newest prediction about "America's New Money." Get the details before it's taken offline. ALXO Media Mentions By Week ALXO Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ALXO News Sentiment▼0.690.44▲Average Medical News Sentiment ALXO News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ALXO Articles This Week▼102▲ALXO Articles Average Week Get ALX Oncology News Delivered to You Automatically Sign up to receive the latest news and ratings for ALXO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Zentalis Pharmaceuticals News Today 89bio News Today Praxis Precision Medicines News Today OPKO Health News Today Arcutis Biotherapeutics News Today ARS Pharmaceuticals News Today Evolus News Today ABIVAX Société Anonyme News Today Ocular Therapeutix News Today Tango Therapeutics News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ALXO) was last updated on 5/10/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsHe Is Giving Away BitcoinCrypto Swap ProfitsTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaGold Set to EXPLODE!Gold Safe ExchangeCharles Payne Demystifies OptionsUnstoppable ProsperityForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingMissed NVDA? Buy this AI stock NOWChaikin AnalyticsYou need to know these two things about AI stocks ASAP…InvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ALX Oncology Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
